Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform

Launched by SIGNOS INC · Nov 4, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at how using continuous glucose monitoring (CGM) can help people who do not have diabetes but want to lose weight or improve their overall health. The study will involve participants using the Signos mobile health app, which will track their glucose levels and provide coaching and nutrition education. The goal is to see if this combination can help people make better choices about their diet and exercise, leading to weight loss and improved health outcomes.

To join the study, participants need to be at least 18 years old, own a smartphone, and be comfortable using the Signos app in English. They will also need to fill out some surveys and provide information about their weight and health. However, people with diabetes, certain medical conditions, or a history of eating disorders cannot participate. This trial aims to find new ways to support weight management in the general population, potentially helping many people achieve their health goals.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years and above
• • Own a smartphone and be willing to install the Signos App to use the app, receive messages or notifications, and input weight and other data.
• • Willingness to complete questionaries or other surveys
• • Able to speak and read English
• Exclusion Criteria:
• • Medical diagnosis of Type 1 Diabetes
• • Medical diagnosis of Type 2 Diabetes
• • Current medical diagnosis of an eating disorder (anorexia or bulimia) or previously struggled with disordered eating behaviors with current BMI less than 24
• • Medical conditions (e.g., such as seizure disorder) requiring a specific medical diet.
• • Inborn errors of metabolism such as phenylketonuria (PKU), glycogen storage disease, fructose intolerance, Maple Sugar Urine Disease (MSUD).
• • Chronic or severe disease (e.g, chronic obstructive pulmonary disease \[COPD\], coronary artery disease, cerebrovascular accident \[CVA\], or cardiac arrhythmia) that would preclude a subject from safely participating in dietary recommendations and/or physical activity
• • History of Gastric bypass or other bariatric surgery
• • History of 10 or more soft tissue skin infections (such as cellulitis or abscesses)
• • Intolerable skin reaction from adhesive
• • Currently taking any of the following medications: Hydroxyurea, insulin, sulfonylureas, or medications prescribed specifically for the treatment of diagnosed diabetes
• • Vulnerable populations such as minors, prisoners, or pregnant women will not be enrolled in this study. Women who become pregnant will be excluded at that time.
• • Inability or unwillingness of subject to give informed consent